Michael Wirth
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 32
- Advancements in Transdermal Drug Delivery 8
- Biomaterials 32
- Nanoparticle-Based Drug Delivery 32
- Co-authors
- Franz Gabor (77 shared papers)Claudia Valenta (10 shared papers)Helmut Viernstein (9 shared papers)Stefan Toegel (9 shared papers)Fritz Pittner (6 shared papers)Lukas Neutsch (10 shared papers)Winfried Neuhaus (8 shared papers)Juan M. Irache (1 shared paper)
- Journals
- International Journal of Pharmaceutics (13 papers)Journal of Controlled Release (10 papers)European Journal of Pharmaceutics and Biopharmaceutics (10 papers)Pharmaceutical Research (5 papers)Acta Biomaterialia (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Wirth
99 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 108
- Pharmaceutical Science 985
- Biomaterials 698
- Drug Discovery 10
- Neurology 159
- Molecular Medicine 81
Countries citing papers authored by Michael Wirth
This map shows the geographic impact of Michael Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wirth more than expected).
Fields of papers citing papers by Michael Wirth
This network shows the impact of papers produced by Michael Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wirth. The network helps show where Michael Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 227 | |
| 2 | 2002 | 119 | |
| 3 | 2004 | 91 | |
| 4 | 1999 | 85 | |
| 5 | 2010 | 84 | |
| 6 | 2006 | 82 | |
| 7 | 1998 | 74 | |
| 8 | 1988 | 73 | |
| 9 | 2003 | 72 | |
| 10 | 1998 | 71 | |
| 11 | 2002 | 68 | |
| 12 | 2007 | 60 | |
| 13 | 2013 | 60 | |
| 14 | 2004 | 57 | |
| 15 | 2004 | 54 | |
| 16 | 2000 | 53 | |
| 17 | 1997 | 49 | |
| 18 | 2008 | 49 | |
| 19 | 2008 | 48 | |
| 20 | 2011 | 48 |
About Michael Wirth
Michael Wirth is a scholar working on Pharmaceutical Science, Biomaterials, Neurology, Molecular Biology and Oncology, having authored 99 papers that have together received 3k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (32 papers), Nanoparticle-Based Drug Delivery (32 papers), Glycosylation and Glycoproteins Research (19 papers), Advancements in Transdermal Drug Delivery (8 papers), Barrier Structure and Function Studies (7 papers), Drug Transport and Resistance Mechanisms (6 papers), DNA and Nucleic Acid Chemistry (4 papers) and 3D Printing in Biomedical Research (4 papers). The work is most often cited by research in Pharmaceutical Science (985 citations), Biomaterials (698 citations), Drug Discovery (10 citations), Neurology (159 citations) and Molecular Medicine (81 citations). Michael Wirth has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Franz Gabor, Claudia Valenta, Helmut Viernstein, Stefan Toegel, Fritz Pittner, Lukas Neutsch, Winfried Neuhaus, Juan M. Irache, Christian R. Noe and Miguel Angel Arangoa. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.